Contact
Please use this form to send email to PR contact of this press release:
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
TO:
Please use this form to send email to PR contact of this press release:
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
TO: